Deep Dive Series: COVID-19 Delta Variant- New approaches needed
8:30-10:00 a.m., Friday, September 3, 2021
(The speech and Q & A will be in English.)
Current levels of infection with the Delta variant of the novel coronavirus and the consequent inability of the health system to cope with further increases in numbers of people requiring isolation, oxygen supplies and hospitalization, show that approaches taken by the government up to now have to change.
How can Japan make testing more widely available, and increase hospital capacity for COVID patients? What progress is being made in vaccination efforts and in tackling the increased risk to unvaccinated young people? Are tighter lockdowns the answer?
The Deep Dive Task Force has secured the expertise of two eminent medical specialists to address these and other key issues related to the COVID-19 pandemic.
- Dr. Kiyoshi Kurokawa: A graduate of the University of Tokyo, School of Medicine, Dr. Kurokawa spent 15 years in the US from 1969-84, where he was professor of medicine at UCLA. He was Dean of Tokai University Medical School, President of the Science Council of Japan, and Science Advisor to the Prime Minister of Japan. He was Chair of the Fukushima Nuclear Accident Independent Investigation Commission by the National Diet of Japan. Now he is Vice Chair of the World Dementia Council established by G8 (now G7) London Dementia Summit in 2013 and Chair of the Covid-19 AI Advisory Board appointed by Minister Nishimura in July 2020. Website:https://kiyoshikurokawa.com/en//
- Dr Kenji Shibuya: He is currently Director, Soma COVID Vaccination Medical Center in Soma City, Fukushima. He was previously Professor and Director of the University Institute for Population Health at King’s College London. Before joining Kings, he was Professor and Chair of the Department of Global Health at the University of Tokyo. His expertise ranges across important topics in global and population health including health metrics and evaluation; global burden of disease; health system performance; product and system innovations; public-private partnerships; and R&D strategies. Dr. Shibuya has been an advisor to both central and local governments, and most recently he was Special Advisor to the Director-General of the World Health Organization (WHO) and a member of the Scientific Advisory Committee of Coalition for Epidemic Preparedness Innovations (CEPI), a pandemic vaccine fund, investing in COVID-19 vaccines. He spearheaded the future strategic directions of the Japanese global health policy agenda at the Hokkaido Toyako G8 Summit in 2008 on health system strengthening and Ise-Shima G7 Summit in 2016 on global health security. He obtained his MD at the University of Tokyo and earned a doctorate of public health in international health economics at Harvard University.
Please indicate when signing up whether you will attend on-line or in-person.
Members: 450 yen (including tax), coffee or tea included
Non-members: 1,650 yen (including tax), coffee or tea included
Members: free of charge
Non-members: 550 yen (including tax)
Details on how to join online will be sent to individual emails by September 2.
All participants can reserve at the reception desk or by email ( firstname.lastname@example.org ).
Members should Log in to confirm attendance.
Payment by Non-Members must be made in advance by 3 PM, September 1.
No refund is available unless the event is cancelled by FCCJ.
Member reservations cancelled less than 24 hours before the event will be charged in full.
We kindly ask for your cooperation with Covid-19 prevention measures at the
reception and to wear a mask on club premises.
Professional Events Task Force